About the Business Unit

The network of manufacturers, customers, service providers and authorities that we have built up over many decades in the business with active pharmaceutical ingredients and excipients has now been successfully used for over 15 years in the business with finished medicinal products. 

A major trend in the industry for many years has been the growing share of in-licensing in the finished drug portfolio of pharmaceutical companies. Cost pressure and a constantly growing number of products mean that not every product can be developed independently by these companies. In this context, WELDING has been a reliable partner for large, medium-sized and small pharmaceutical companies worldwide for many years with its range of finished drug formulations.

With our services in the areas of quality, regulatory affairs and supply chain management, we go beyond the basic licensing business with finished drug dossiers and thus provide our customers with a holistic offer from a single source: